Exencial Wealth Advisors LLC Buys 711 Shares of iShares Nasdaq Biotechnology ETF (IBB)

Exencial Wealth Advisors LLC increased its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 21.8% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 3,978 shares of the financial services provider’s stock after purchasing an additional 711 shares during the period. Exencial Wealth Advisors LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $384,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Pinnacle Wealth Management Advisory Group LLC increased its position in shares of iShares Nasdaq Biotechnology ETF by 10.9% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,545 shares of the financial services provider’s stock valued at $245,000 after purchasing an additional 250 shares during the last quarter. Parallel Advisors LLC increased its position in shares of iShares Nasdaq Biotechnology ETF by 5.8% during the 4th quarter. Parallel Advisors LLC now owns 3,699 shares of the financial services provider’s stock valued at $356,000 after purchasing an additional 204 shares during the last quarter. Westside Investment Management Inc. increased its position in shares of iShares Nasdaq Biotechnology ETF by 3.4% during the 4th quarter. Westside Investment Management Inc. now owns 5,015 shares of the financial services provider’s stock valued at $484,000 after purchasing an additional 165 shares during the last quarter. Fort Washington Investment Advisors Inc. OH increased its position in shares of iShares Nasdaq Biotechnology ETF by 0.8% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 16,998 shares of the financial services provider’s stock valued at $1,639,000 after purchasing an additional 134 shares during the last quarter. Finally, Canal Capital Management LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at about $1,186,000. 66.51% of the stock is currently owned by institutional investors and hedge funds.

Get iShares Nasdaq Biotechnology ETF alerts:

Shares of iShares Nasdaq Biotechnology ETF stock opened at $109.67 on Thursday. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.

ILLEGAL ACTIVITY NOTICE: This article was first published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/4151993/exencial-wealth-advisors-llc-buys-711-shares-of-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: How Do I Invest in Dividend Stocks

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).